Syngene International Limited (NSE:SYNGENE)
India · Delayed Price · Currency is INR 398.65
-1.05 (-0.26%)
Mar 9, 2026, 3:30 PM IST
Syngene International Market Cap
Syngene International has a market cap or net worth of 159.12 billion as of March 9, 2026. Its market cap has decreased by -43.03% in one year.
Market Cap
159.12B
Enterprise Value
154.03B
Revenue
37.20B
Ranking
n/a
PE Ratio
50.21
Stock Price
398.65
Market Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 159.12B, an increase of 156.19%. That is a compound annual growth rate of 9.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 159.12B | -38.60% |
| Dec 31, 2025 | 259.16B | -24.09% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.28T |
| Divi's Laboratories | 1.69T |
| Apollo Hospitals Enterprise | 1.11T |
| Cipla | 1.07T |
| Eris Lifesciences | 188.49B |
| Sagility | 183.55B |
| NATCO Pharma | 182.64B |
| OneSource Specialty Pharma | 169.70B |